Merrimack Pharmaceuticals...

NASDAQ: MACK · Real-Time Price · USD
15.14
0.01 (0.07%)
At close: May 17, 2024, 9:59 PM

Merrimack Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-162.36 -100.38 -21.35
PEG Ratio
6.52 2.58 0.98
PS Ratio
n/a n/a n/a
PB Ratio
10.23 8.05 3.70
P/FCF Ratio
-125.99 -88.97 -240.47
P/OCF Ratio
-125.99 -88.97 -240.46
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
n/a n/a n/a
Quick Ratio
43.50 33.66 26.13
Current Ratio
43.50 33.66 26.13
Asset Turnover
n/a n/a n/a
Interest Coverage
n/a n/a n/a
Return on Equity
-0.06 -0.08 -0.17
Return on Assets
-0.06 -0.08 -0.17
Return on Invested Capital
-0.12 -0.09 -0.17
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a